ATP11B Knockout HEK293T Cell Line
Cat.No.:
EDC07530
Species:
Human
Cell Name:
HEK293T
Gene:
ATP11B
Gene ID:
23200
Size:
1×10⁶cells
ATP11B Knockout HEK293T Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07530 |
|---|---|
| Product Name | ATP11B Knockout HEK293T Cell Line |
| Species | Human |
| Cell Line | HEK293T |
| Cellosaurus ID | CVCL_0063 |
| Cell Line Synonyms | Hek293T, HEK-293T, HEK 293T, HEK-293-T, HEK 293 T, 293-T, 293 T, 293T, Human Embryonic Kidney 293T, 293tsA1609neo |
| Gene ID | |
| Gene | ATP11B |
| Summary |
P-type ATPases, such as ATP11B, are phosphorylated in their intermediate state and drive uphill transport of ions across membranes. Several subfamilies of P-type ATPases have been identified. One subfamily transports heavy metal ions, such as Cu(2+) or Cd(2+). Another subfamily transports non-heavy metal ions, such as H(+), Na(+), K(+), or Ca(+). A third subfamily transports amphipaths, such as phosphatidylserine.[supplied by OMIM, Feb 2005]
|
| Associated Diseases | Non-tumor |
| Digestion Time | 30 sec~1 min |
| Morphology | Adherent |
| Passage Ratio | 1:5 |
| Complete Culture Medium | DMEM+10% FBS+1% NEAA+1% GlutaMax |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293T | STR Info (Cell bank) Cell Line: HEK293T | ||||
| Allele1 | Allele2 | Allele3 | Allele1 | Allele2 | Allele3 | |
| Amelogenin | X | X | ||||
| CSF1PO | 11 | 12 | 11 | 12 | ||
| D2S1338 | 19 | 19 | ||||
| D3S1358 | 15 | 16 | 17 | 15 | 16 | 17 |
| D5S818 | 8 | 9 | 8 | 9 | ||
| D7S820 | 11 | 11 | ||||
| D8S1179 | 11 | 12 | 14 | 12 | 14 | |
| D13S317 | 12 | 14 | 12 | 14 | ||
| D16S539 | 9 | 13 | 9 | 13 | ||
| D18S51 | 17 | 18 | 17 | 18 | ||
| D19S433 | 18 | 18 | ||||
| D21S11 | 28 | 30.2 | 28 | 30.2 | ||
| FGA | 23 | 23 | ||||
| Penta D | 9 | 10 | 9 | 10 | ||
| Penta E | 7 | 15 | 7 | 15 | ||
| TH01 | 7 | 9.3 | 7 | 9.3 | ||
| TPOX | 11 | 11 | ||||
| vWA | 16 | 19 | 16 | 19 | ||
| D6S1043 | 11 | |||||
| D12S391 | 19 | 21 | 19 | 21 | ||
| D2S441 | 11 | 15 | 11 | 15 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying ATP11B function, ATP11B Knockout HEK293T Cell Line or ATP11B overexpression HEK293T Cell Line?
The choice depends on whether you are studying ATP11B's role as a P4-type ATPase phospholipid flippase or modeling its emerging functions in cisplatin resistance and lipid asymmetry. The Knockout line is the standard tool for asking whether ATP11B is required for these processes — ATP11B is a P4-type ATPase phospholipid flippase that, together with the β-subunit CDC50A/TMEM30A, translocates phosphatidylserine (and to lesser extent PE) from the outer to inner leaflet of the plasma membrane to maintain phospholipid asymmetry; ATP11B has emerged as a mediator of cisplatin resistance and is implicated in white matter brain injury. Overexpression is useful for studying ATP11B gain-of-function effects.
For lipid biology and cancer drug resistance research, the EDITGENE ATP11B Knockout in HEK293T is highly informative — HEK293T's very high transfection efficiency supports systematic structure-function studies. Rescue with wild-type or catalytically-dead ATP11B enables structure-function studies. The knockout is valuable for studying phospholipid flippase biology, cisplatin resistance mechanisms, and emerging ATP11B functions in neurological and cancer applications.
What are the application scenarios for this model?
Primary applications:
• Phosphatidylserine flipping: PS asymmetry analysis (annexin V exposure, lactadherin staining) in ATP11B-null cells.
• Cisplatin resistance: in cisplatin-treated cells, ATP11B-mediated resistance mechanism studies.
• White matter biology: in heterologous neural-relevant contexts, ATP11B's reported role in oligodendrocyte biology.
• CDC50A partnership: TMEM30A/CDC50A β-subunit interaction analysis.
EDITGENE recommends this HEK293T-based model for researchers investigating phospholipid flippase biology and emerging ATP11B-related cancer drug resistance.
Is this ATP11B Knockout HEK293T Cell Line compatible with overexpression rescue experiments?
Yes. ATP11B rescue experiments require attention to P4-ATPase architecture:
• Construct design: use a codon-modified ATP11B sequence with a small intracellular tag (FLAG, HA). ATP11B is a P4-type ATPase with 10 transmembrane spans, cytoplasmic A, N, P domains — preserve membrane topology.
• CDC50A partnership: rescue interpretation considers CDC50A/TMEM30A β-subunit expression for proper flippase function.
• Catalytically-dead rescue: P-domain phospho-aspartate mutations abolish ATPase/flippase activity.
• Functional readout: rescue should restore phosphatidylserine flipping activity.
HEK293T transduces with very high efficiency and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download